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ABSTRACT
Apoptosis Pathways:
Presence and Significance in Ejaculated Human Spermatozoa
Steven Lewis Taylor
Old Dominion University, 2002
Co-Director: Dr. Sergio C. Oehninger
Co-Director: Dr. Mahmood S. Morshedi
Co-Director: Dr. R. James Swanson
Ejaculated sperm display markers that are indicative of apoptosis in
somatic cells. The question remains as to whether sperm have operative
apoptosis mechanisms. The aim of this research was to test the hypothesis
that apoptosis markers in sperm and somatic ceils are different.
Ejaculated human sperm from patients and donors were separated into
high and low motility fractions using Percoll™ gradients. Contaminating cells
were removed using anti-CD45 conjugated paramagnetic beads. Fractions
were divided into groups: staurosporine, anti-Fas antibody, and hydrogen
peroxide treated and control. Direct enzymatic measurement of caspase
activity, flow cytometric evaluation of phosphatidylserine translocation,
immunoblots, and immunocytochemistry were used in this investigation.
Of the pro-apoptotio treatments, only staurosporine resulted in elevated
caspase activity in patients and donors. Differences in caspase activity were
found between donor and patient sperm. No elevations low motility fraction
caspase activities were detected.
In Annexin-V-FITC labeled high motility fractions, staurosporine, anti-Fas,
and 25 micromolar hydrogen peroxide failed to stimulate phosphatidylsenne
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translocation. However, 200 micromolar hydrogen peroxide resulted in
translocation increases. No treatment stimulated translocation in low motility
fractions.
In immunoblots, the presence of procaspase-3 was detected in high and
low motility fractions from donors and patients. Active caspase-3 was
detected in high and low motility fractions from donors and patients.
Procaspase-7, but not active, was also detected. Procaspase-9 was detected
in high and low motility fractions from donors and patients. Active caspase-9
was only detected in a low motility patient fraction. Neither intact Poly-ADPribose Polymerase nor its breakdown product was detected. Apoptosis
Inducing Factor was present in immunoblots from all high and low motility
fractions. BID was not detected in either high or low motility fractions.
Active caspase-3 was detected using immunofluorescent microscopy in
severe oligoasthenoteratozoospermic patients. Less than one percent of the
sperm evaluated exhibited active caspase-3.
Sperm possess apoptosis markers. However, pro-apoptotic treatments
indicated that apoptosis was not fully inducible in sperm. Sperm lack major
signals associated with caspase dependent apoptosis in somatic cells. Since
mitochondria are the only active organelle present in sperm, further work must
be done to determine whether mitochondria dependent pathways are intact.
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CHAPTER I
INTRODUCTION
DEFINING APOPTOSIS
The term apoptosis derives from Greek terminology that is used to
describe the shedding of leaves. Apoptosis was first coined by Kerr e ta i,
(1972) in a landmark paper describing a process of cell death distinct from
necrosis in that it was the result of a normal physiological process in
ontogeny. It was also known at this time that this newly described process
could be induced through treatment with noxious stimuli.
Kerr's determination of apoptosis was based on morphological criteria.
Cells classified as apoptotic had already separated themselves from other
cells if part of a tissue. Apoptotic cells demonstrated pronounced
condensation of the cell nucleus. Another noteworthy characteristic of
apoptosis was membrane protuberances or “blebbing” and subsequent
formation of apoptotic bodies. Apoptotic bodies were observed to contain cell
organelles that appeared to be intact structurally as well as functionally. Other
cells soon phagocytized the by-products of apoptosis. A distinguishing
characteristic in apoptosis compared with necrosis was the lack of
inflammation in apoptosis. Kerr also suggested that apoptosis plays a vital
role in maintenance of normal tissue homeostasis and during embryonic
development.

The model journal for this dissertation was Human Reproduction.
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PS translocation can occur under several mechanisms. During apoptosis,
APT is inhibited and phospholipid scramblases are activated, resulting in the
exposure of PS on the outer leaflet of the plasma membrane. This change
stimulates the removal of apoptotic cells by phagocytes (Fadok e ta i, 1992;
Fadok e ta i, 2001; Hoffmann et a!., 2001).
There is some evidence that PS oxidation occurs during apoptosis and
that this modification can adversely affect recognition of PS by APT and
scrambiase (Kagan e ta i, 2000)]. Oxidation of cysteine residues by reactive
oxygen species (ROS) on APT inactivates the enzyme (de Jong e ta i, 1997;
Hermann and Devaux, 1990; Morrot 1989 e ta i, 1989). Hence, failure of APT
to catalyze internalization of PS may be due to inability of the enzyme to
recognize oxidized PS or may be due to inactivation of APT by ROS.
Oxidation of PS, as well as other phospholipids, can also increase their
tendency to spontaneously translocate or “flip” to the outer leaflet of the
plasma membrane (Hampton e ta i, 1996). Although it could not be
discounted, caspase inactivation of APT is not thought to be an exclusive
mechanism (Zhaung e ta i, 1998).
A caspase-3 role in PS translocation was supported by a recent study
(Mandai e ta i, 2002). In this study, erythrocytes were stimulated through
oxidative stress to undergo PS translocation, which was shown to be inhibited,
but not totally abolished, by the caspase-3 inhibitor Z-DEVD-FMK.
Erythrocytes are known to have functional caspases-3 and -9 (Wolf e ta i,
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1999). Further, these cells were determined to have reduced
aminophospholipid translocase (APT) activity.
Caspases are a family of aspartic acid directed cysteine proteases that are
involved in apoptosis. The appearance of active caspases is a well-known
biochemical marker for apoptosis. Caspases are synthesized in an inactive,
proenzyme form. The proenzyme consists of three domains: an NH2-terminal
sequence, a large subunit, and a small subunit. Proteolytic cleavage of the
proenzyme results in separation of the three domains and association, in the
form of heterodimers, of large and small subunits to form the active enzyme.
The presence of caspase concensus sequences at cleavage sites of the
domains in the proenzyme makes these proteins targets for other activated
caspases (Stennicke e ta i, 1998). Alternatively, procaspases may also
activate autocatalytically (Muzio etai., 1998).
The first caspase identified was caspase-1, then known in mammalian
cells as interleukin-1 p converting enzyme (ICE) (Thornberry and Lazebnik
1998). This enzyme, termed CED-3 (cell death abnormal-3) when first
discovered in nematodes was implicated in cell death in Caenorhabditfs
etegans (Ellis and Horvitz 1986) and was found to have sequence homology
to mammalian ICE, also known as caspase-1 (Yuan et a i, 1993). To date, 14
caspases have been discovered. Among them, caspases-3, -9, and -8 are
the best characterized major players in apoptosis.
Caspases are classified as initiator or effector caspases. Initiator
caspases are activated early in apoptosis and often require a co-factor. An
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example of cofactors involved in apoptosis are apoptosis protease activating
factor-1 (Apaf-1) and cytochrome c. Effector or executioner caspases are
downstream of initiator caspases and are activated by initiator caspases.
Caspases -3, -6, and -7 are examples of an effector caspase, downstream of
initiator caspases such ascaspase-8 o r-9 (Thomberry and Lazebnik 1998).
However, caspase-3 is a common point of convergence in both caspase-8
and -9 pathways. Caspase-3 acts to amplify the apoptotic signal by activating
other caspases (-3, -6, and -7) as well as inactivating essential cellular
proteins involved in homeostasis.
During apoptosis, the release of cytochrome c from mitochondria may be a
key event in oxidative modification of PS. Release of cytochrome c from
mitochondria occurs concurrently with a dramatic intracellular increase in
reactive oxygen species (ROS) production and release into the cytosol (Cai
and Jones 1998). These ROS may be directly responsible for oxidation of PS.
Kagan (2000) suggested that cytochrome c might oxidize PS on the cytosolic
face of the plasma membrane and cause an increase in oxidized PS
translocation.
An early event fn apoptosis is a reduction in mitochondrial membrane
potential (A'Fm). This occurs prior to completion of fragmentation of cellular
DNA into oligonucleosomal fragments.

decrease is thought to occur by

formation of pores on the inner mitochondrial membrane during permeability
transition. Permeability transition pores destabilize A'Pm by facilitating
equilibration of ion gradients between the cytoplasm and mitochondrial matrix.
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Alternatively, A'Fmcan be disrupted through a Fas activated pathway. In
this pathway, caspase-8 cleaves the full-length 22 kDa Bid, a cytoplasmic
protein involved in the Fas type II apoptosis pathway (Nagata 1999; Li e ta i,
1998). The shortened 15 kDa Bid protein then proceeds to promote
disruption of AYm by promoting pore formation and facilitating the escape of
cytochrome c (Lou e ta i, 1998), which then promotes caspase cascades and
results in apoptosis (Gross e ta i, 1999). Cleavage of Bid by other caspases
may result in lower molecular weight Bid species (11 and 13 kDa). After
reduction of AvFm, mitochondrial apoptosis promoters escape to the cytosol.
Among them are cytochrome c and Apoptosis inducing Factor (AIF).
AIF is released from the mitochondrial intermembrane space and is
translocated to the nucleus where it promotes DNA fragmentation (Daugas et
a i, 2000). Caspase inhibition has been demonstrated not to affect the
release of AIF and cytochrome c (Daugas e ta i, 2000; Susin e ta i, 1999b).
However, Bcl-2 overexpression inhibits AIF translocation, as BCL-2
counteracts apoptotic signals to mitochondria (Susin e ta i, 1999b). AIF
causes large scale DNA fragmentation (50-200 kb) rather than the
oligonucleosomal fragments seen during later stages of apoptosis. AIF has
also been shown to adversely affect permeability of isolated mitochondria, an
event that could lead to a positive feedback loop intensifying the apoptotic
signal (Susin e ta i, 1999b). The apoptotic effects of staurosporine (STS) can
be counteracted, to a degree by overexpression of Bcl-2. Bcl-2 hinders AIF
and cytochrome c release from mitochondria (Yang e ta i, 1997; Kluck e ta i,
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1997). Staurosporine has been shown to induce AIF release from the
mitochondria concurrent with the release cytochrome c (Daugas e ta i, 2000;
Susin e ta i, 1999b). In addition, it has been found that AIF transport to the
nucleus is energy dependent.
Procaspase-3 has also been found in mitochondria and is likely liberated
from the intermembrane space in its active form during loss of A'Pm(Mancini
e ta i, 1998). In this study, apoptosis was induced in human keratinocytes by
either irradiation with UVB, C2-Ceramide treatment, or staurosporine
treatment. Mitochondrial membrane potential was monitored during treatment
and in control replicates. With staurosporine treatment, cells lacked both the
mitochondrial label indicating intact mitochondrial membrane potential and
caspase-3 staining. Additionally, procaspases-2 and -9 have also been
localized to the intermembrane space in similar studies (Susin e ta i, 1999a).
Poly (ADP-ribose) polymerase-1 (PARP-1) is an approximately 116 kDa
eukaryotic protein that functions to help repair DNA damage. PARP-1 activity
increases with increasing DNA fragmentation (Haildorsson e ta i, 1978).
Currently, four PARP enzymes have been discovered. PARP-1 functions to
bind to and catalyze the repair of DNA strand breaks. During apoptosis,
PARP-1 is inactivated by one or more of caspases-3, -7, and/or-9. The
inactive PARP-1, like caspase activation, is a telltale marker of active
caspase-dependent apoptosis pathways.
DNA fragmentation in apoptosis is the culmination of the combined
influences of a number of pathways. In apoptotic cells, caspase cascades
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result in the activation of Caspase Activated DNase (CAD), which acts on
DNA to produce oligonucleosomal fragmentation. DNA is initially digested into
segments ranging from 50-200 kb (Susin e ta i, 1999b; Oberhammer e ta i,
1993; Lagarkova etai., 1995). Later, DNA is cleaved into smaller,
nucleosomal units. Apoptosis also requires new mRNA and protein synthesis
in early stages (Kidd 1998).
Caspase-3 acts to amplify the cell death signal and eventually activates
CAD. CAD is initially associated with ICAD (inhibitor of CAD). Caspases
target ICAD and cause disassociation of ICAD and CAD, activating the CAD
enzyme (Nagata 2000). CAD is responsible for nuclear DNA fragmentation in
apoptotic cells. Caspase-3 also inactivates PARP-1, a protein involved in the
repair of DNA damage. The result is a fail-safe system in which caspase-3
activation ultimately leads to DNA fragmentation while simultaneously
inactivating DNA repair mechanisms.
APOPTOSIS INDUCTION
Apoptosis is, in many cases, initiated by the binding of the Fas ligand
(FasL) to extracellular receptors (CD95). FasL is a type II 40 kDa membrane
protein in the tumor necrosis factor (TNF) protein family. In vivo, a common
apoptosis inducer is the FasL. FasL is expressed by immune cells of T-cell
lineage and natural killer cells (Sudaef a lt 1995; Oshimi e ta i, 1996). FasL
binds to a Fas/APO-1/CD95 receptor that has been found in cells targeted for
apoptosis. Fas stimulated apoptosis results from trimerization of Fas
receptors. Experimentally, Fas receptors can be cross-linked using
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recombinant FasL and certain stimulatory antibodies (Trauth etai., 1989;
Rokhlin etai., 1997). Fas receptors are a type I membrane protein.
Two major apoptotic signaling schemes are seen in cells undergoing CD95
stimulated apoptosis. These two pathways have come to be known as Type I
and Type II pathways. Typically, one pathway will predominate (cell type
dependent) and the other will play a supportive or reinforcement role. The
determination of whether a particular cell type reacts to apoptotic stimuli in a
type I or type II manner depends upon the amount of active caspase-8
generated by the trimerization of CD95 receptors. Generation of large
amounts of caspase-8 result in the assumption of the type I pathway, while a
much more modest caspase-8 recruitment results in the cell taking the type II
route (Scaffidi e ta i, 1998).
In Type I cells, apoptosis FasL binding causes trimerization of Fas
receptors (APO-1 or CD95). Fas receptors have associated with them an
adaptor molecule, the Fas Associated Death Domain (FADD). FADD binds to
Fas through carboxy-terminal death domain interactions. An N-terminal area
of FADD is called a death effector domain (DED) that binds to N-terminal
DED domain located on procaspase-8. The association of these molecules is
termed the death inducing signaling complex (DISC). Procaspase-8 has
some protease activity and, under these conditions, the enzyme activates
through autocatalysis during oligomerization. Hence, trimerization of Fas
receptors and their associated FADD causes processing of procaspase-8 into
its active form (Nagata 1997). A hallmark of type I Fas mediated apoptosis is
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the recruitment of large amounts of caspase-8. Within seconds of Fas
trimerization, caspase-8 is activated, which then activates caspases-3, -6, and
-7.
In Type II cells, apoptosis is also initiated by the binding of FasL or through
chemical stimuli and primarily involves mitochondrial factors. Recruitment of
DISC is drastically reduced compared with type I cells, although adequate
component proteins are present. Apoptosis inducing conditions cause
reduction of AxFmand the escape of major apoptotic mitochondrial associated
proteins such as cytochrome c and AIF. In Fas mediated pathways, activation
of caspase-8 results in the cleavage of Bid. The truncated form of Bid is a
pro-apoptotic factor that, in turn, triggers the loss of mitochondrial
transmembrane potential (A'Pm).
Stimulation of the release of cytochrome c from mitochondria initiates an
apoptotic cascade in type II cells. Cytochrome c and the cytoplasmic protein
Apaf-1 contribute to the activation of caspase-9. Apaf-1 is a 130 kDa protein
with an N-terminal caspase recruitment domain (CARD) that binds to
procaspase-9 proteins. Apaf-1 first binds to and hydrolyzes dATP in the
presence of cytochrome c, forming a multimeric ApaM/cytochrome c
complex. This complex then associates with procaspase-9 proteins, resulting
in autocatalytic activation of caspase-9. The ApaM/cytochrome
c/procaspase-9 complex is termed the apoptosome (Li e ta i, 1997).
Caspase-9 serves to activate effector caspases-3, -6, and -7. AIF,
released into the cytosol along with cytochrome ct is transiocated to the
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nucleus where it promotes DNA fragmentation through an unknown
mechanism. Type II responses can be countered by overexpression of two
anti-apoptotic proteins, BCL-2 and/or BCL-xl.
Timeline differences in the activation of major apoptotic enzymes are also
markedly different between type I and type II cells (Scaffidi etai., 1998). In
type I cells, recruitment of large amounts of caspase-8 is immediate and
caspase-3 recruitment can be recognized within 30 minutes. Additionally,
type I cells are not susceptible to the anti-apoptotic effects of overexpression
of BCL-2 and B C L-xl. In type II cells, recruitment of large amounts of
caspase-8 does not occur until as late as an hour after CD95 stimulation. In
type II cells, activation of the caspase cascade can be inhibited altogether by
BCL-2 mediated inhibition of the release of mitochondrial pro-apoptotic
factors.
Alternative designations of caspase-dependent and caspase-independent
have also been used to classify cellular pathways. Caspase-dependent
pathways involve activating caspases during initiation of apoptosis. Caspaseindependent pathways of apoptosis generally invoive mitochondrial factors. In
many cell types, cross-activation and reinforcement between caspase
dependent and independent pathways occurs.
Apoptosis can be experimentally induced in somatic cells using any
number of stimuli. Early studies induced apoptosis through exposure to
ionizing radiation. Irradiation was found to induce PS transiocation (Vermes
e ta i, 1995).
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marker for incomplete spermatogenesis or as an indicator for immature
sperm. Cytoplasmic droplets are composed of unnecessary or discarded
cellular material unused during spermatogenesis and are normally
phagocytized by sertoli cells.
Since the use of morphological criteria to demonstrate apoptosis in
ejaculated spermatozoa is precluded by the unique specializations of this cell
type, attention must be turned towards biochemical means of evaluating the
question of whether apoptosis occurs in sperm. Few biochemical markers of
apoptosis have been demonstrated in sperm.
DNA fragmentation, an important end result of apoptosis, has been
demonstrated in sperm. Aitken, et al. (1998), demonstrated that DNA damage
in sperm was associated with high levels of reactive oxygen species in sperm
fractions.
The presence of caspase-3 in sperm has been reported in one previous
study (Weng e ta i, 2002). However, active caspase-3 was only detectable by
immunofluorescent microscopy in a small percentage of the sperm evaluated.
Enzymatic measurements of caspase activity were similarly low in untreated
patient and donor sperm fractions.
A single previous report of PARP-1 presence in sperm fractions has been
published. Blanc-Layrac, et. al. (2000) reported that both the intact 116 kDa
and the caspase modified 85 kDa forms of PARP-1 were present in fractions
from semen samples. Three fractions were derived from each sample: whole
semen, washed semen, and motile sperm separated by density gradient
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centrifugation. Both 116 kDa and 85 kDa forms of PARP-1 were observed in
the whole semen and washed semen fractions. The 85 kDa form was
specifically mentioned as not being present in sperm fractions isolated by
density gradient centrifugation. Curiously, no mention was made of whether
intact PARP-1 was observed in this fraction. No other studies have been
published investigating the presence of PARP-1 in sperm fractions.
AIF is a mitochondrial protein that is released and is translocated to the
nuclei of somatic cells undergoing apoptosis. AIF alone is sufficient stimulus
to induce apoptotic changes to isolated nuclei (Susin etai., 1999b). AIF is
associated in somatic ceils with Type II or mitochondrial dependent
mechanisms of apoptosis. AIF has not been previously demonstrated in
ejaculated spermatozoa.
It has been suggested that apoptosis markers may be used as semen
quality indicators (Jurjen et al., 2000). Assays were proposed to detect two
common apoptosis markers, PS transiocation and DNA fragmentation. The
assay used for the detection of PS transiocation was flow cytometric
evaluation of Annexin-V-FITC binding to PS in sperm plasma membranes,
using propidium iodide (PI) as a counterstain for viability. PI binds to DNA and
is membrane impermeable, hence serving as a reliable indicator of intact
plasma membranes. Inverse correlations were found between Annexin-VFITC binding and concentration and motility.
The TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick
end labeling) assay was used to detect DNA fragmentation. TUNEL results

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

15

indicated an inverse correlation between concentration and DNA
fragmentation, but no correlation between TUNEL positive (DNA
fragmentation) and Annexin-V binding (PS transiocation) could be detected.
Although the suggestion that sperm undergo apoptosis is intriguing, no
evidence has yet been presented to indicate that sperm do, in fact, undergo
the process. Recent studies have indicated that PS transiocation occurs
during acrosome reaction (Gadellaand Harrison 2000 and 2002). Annexin-V
binding in ejaculated spermatozoa, then, may merely be indicative of the early
stages of acrosome reaction.
SPECIFIC AIMS
1. To identify changes in ejaculated sperm normally associated with
apoptosis in somatic cells.
The working hypothesis for this specific aim is that ejaculated human
spermatozoa undergo membrane associated changes similar to those
seen in apoptotic somatic cells.
2. To determine the presence of caspases in ejaculated sperm and whether
they can be initiated by known pro-apoptotic agents.
The working hypothesis for this aim is that ejaculated human sperm
express procaspases that are capable of becoming activated by
treatments known to promote apoptosis in somatic cells.
3. To identify key apoptotic proteins in ejaculated sperm.
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CHAPTER II
MATERIALS AND METHODS
INSTITUTIONAL REVIEW BOARD (IRB) APPROVAL
These studies were approved by the Eastern Virginia Medical School
Institutional Review Board (IRB).
SUBJECTS
Subjects were drawn from pools of two main groups. Donor semen
samples were obtained through cooperation with the Jones Institute Cryo
Laboratory sperm bank. Patient semen samples were drawn from two
populations: All patients were consulting for primary infertility at the Jones
Institute for Reproductive Medicine. Forcaspase activity assays, samples
were obtained from patients with otherwise normal semen samples who were
consulting for primary infertility. A second group of patients exhibited
oligozoospermia (sperm concentrations below 20 x 106/milliliter (mL) and
motility below 40%). Semen samples were collected by masturbation
following a period of sexual abstinence of a minimum of two days and a
maximum of five days. Patients with a history of antisperm antibodies were
excluded from the studies or with round cell concentrations in excess of
1x10s/mL.
SAMPLE PREPARATION
SEMEN ANALYSIS
Donor and patient semen samples were allowed to liquefy for at least 30
minutes prior to semen analysis. Samples were evaluated for sperm
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concentration, sperm motility, sperm morphology, and round cell
concentration.
Five pL of raw semen was placed on a Makler™ chamber and evaluated
using a Hamilton-Thorne™ computer assisted semen analyzer (CASA) IVOS
version 10.8 (Hamilton Thorne Research, Beverly, MA). Measurements were
performed in duplicate, with concentration and motility manually verified upon
completion of CASA measurements. Viability was performed as previously
published (Eliasson 1971) as part of the standard semen analysis, before the
start of incubations, and immediately after completion of incubation periods.
A 0.5% (w/v) solution of Eosin Y (C.1.45380, Sigma, St. Louis, MO) in saline
was mixed with the sample in a 1:3 ratio. Twenty pL of the suspension was
placed on a microscope slide, coverslipped, and evaluated. Live sperm, with
intact membranes, excluded the dye and appeared white. Sperm with
compromised membranes were stained red.
Sperm morphology smears were prepared by placing 5 pL droplets of
semen on a microscope slide and smearing droplets with a clean second
slide. Slides were allowed to dry at 37° C. Dried smears were stained using
Diff-Quik™ stain (Dade Behhng AG, Dudingen, Switzerland). Morphology was
assessed using Strict Criteria (Menkveld e ta l, 1990). A minimum of 200
sperm were evaluated on each slide.
Semen samples not meeting or exceeding World Health Organization
(World Health Oorganization, 1999) requirements for normal semen with
respect to concentration, motility, and round cell concentration were rejected
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for all assays except for caspase immunofluorescent microscopy. Round cells
were Identified using a peroxidase staining method for neutrophils. Sperm
morphology, although evaluated for statistical purposes, was not an exclusion
factor when abnormal. Upon completion of diagnostic testing, suitable semen
samples were identified based upon preliminary results of the semen
analyses.
PERCOLL™ SEPARATION
With the exception of semen specimens used for Caspase-3
immunofluorescence microscopy, all semen samples were separated using
Percoll™ (Sigma, St. Louis, Missouri) density gradient centrifugation into high
(90% isotonic Percoll™) and low (45% isotonic Percoll™) motility fractions.
Isotonic Percoll™ was prepared by mixing Percoll™ with 10K concentrated
synthetic Human Tubal Fluid (HTF, Irvine Scientific, Santa Ana, California)
culture medium in a 1:10 ratio. The resulting mixture was used as 100%
isotonic Percoll™. Isotonic 90% Percoll™ was prepared by adding HTF
medium supplemented with 0.2% human serum albumin (HSA, Irvine
Scientific) in a 1:10 ratio. Forty-five percent isotonic Percoll™ was then
prepared by 1:2 dilution of 90% Percoll™ with HTF medium, supplemented
with 0.2% (volume/volume) HSA supplemented HTF medium.
Separation gradients were prepared by overlaying t mL of 90% Percoll™
with 1 m Lof 45% Percoll™ in 15 mL conical centrifuge tubes (Fisher Scientific,
Pittsburgh, PA). Great care was taken during overlaying to prevent mixture of
the two layers and to preserve a stable interface between the two layers. A
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maximum of 2 mL of raw semen was layered onto the 45% Percoll™ layer.
Samples with volumes greater than two 2 were split equally among several
conical centrifuge tubes.
Centrifugation was carried out at 546 xg for 20 minutes. Pellets containing
motile sperm and approximately 0.75 mL of the 90% Percoll™ layers were
removed using fine bore transfer pipets (Fisher Scientific, Pittsburgh, PA). A
fresh transfer pipet was used to remove each layer. The 45%/90% Percoll™
interface, containing mainly immotile sperm, was removed together with
approximately 0.5-0.75 mL of the 45% Percoll layer™. Aspirates were
deposited into appropriately labeled fresh 15 mL conical centrifuge tubes.
Aspirates of each layer there then diluted with two-fold volumes of fresh
HTF-0.2% HSA supplemented medium for a wash phase. Apportioned
samples were centrifuged for 10 minutes at 425 xg to pellet the sperm in the
aspirates. Supernates were removed and discarded. Pellets were
resuspended in 1 mL of fresh HTF with 0.2% HSA.
REMOVAL OF CONTAMINATING NON-SPERMATOGENIC CELLS
Prior to use in assays, cell types of non-spermatogenic lineage that could
complicate, even invalidate, assay results were separated from sperm
fractions. Apoptosis pathways in polymorphonuclear lymphocytes (PMNs) are
well characterized. A primary concern is caspase activity due to
contamination with PMNs. Relatively abundant proapoptotic factors from
these cells could faisely elevate activity measurements from sperm fractions.
Major contaminants of semen include cell types of hematopoietic lineage that
j
|

s
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express CD45 immunologic markers. A reliable method of removing CD45positive cells is the use of anti-CD45 conjugated paramagnetic beads.
Previous studies have validated this method (Krausz etal., 1992).
Percoll™ separated samples were incubated with anti-CD45 conjugated
Dynabeads (Dynal, Lake Success, NY) for 30 minutes. Anti-CD45 Dynabeads
are paramagnetic beads conjugated with Anti-CD45 antibodies. When mixed
with cellular suspensions, anti-CD45 Dynabeads function to bind, with high
specificity, cells expressing CD45 on their outer membrane. The cell
suspension is then subjected to a strong magnetic field from a Magnetic
Particle Concentrator (MPC-L, Dynal) through a glass centrifuge tube (Fisher
Scientific, Pittsburgh, PA), allowing the removal of the remaining cell
suspension. Dynabeads were well mixed by vortexing prior to distribution into
centrifuge tubes. Twenty-five pL of Dynabeads were distributed to centrifuge
tubes using an appropriate pipetand subjected to a magnetic field for two
minutes to remove the antibody coated paramagnetic beads. The remaining
fluid was removed using a 25 p.L pipet. The tubes were removed from the
magnetic field and resuspended in excess washing buffer (phosphate
buffered saline [PBS] supplemented with 0.1% [weight/volume] Bovine Serum
Albumin [BSA]). The resuspended beads were subjected to the magnetic field
for another two minutes and excess binding buffer was removed. Beads were
then resuspended to their original volume and allowed to stand until just
before use.
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The beads were subjected to the magnetic field once again for two
minutes and the excess fluid removed. This time, however, the beads were
resuspended with a maximum of 1 mL of either motile (90% Percoll™) or
immotile (45% Percoll™) sperm suspension. The cell suspension was shaken
gently for thirty minutes. Upon completion of the timed incubation, the
suspension was again subjected to a magnetic field to discard the beads
together with their bound CD45-positive cells. The immunodepleted cell
suspension was then used forcaspase activity assays, protein immunoblots,
and flow cytometry assays.
After cellular depletion of CD45-positive cells, sperm fractions were
evaluated for the presence of PMNs using a Makler™ chamber to determine
the concentration of round cells followed by peroxidase staining to determine
the percentage of round cells that were PMNs. Samples containing more than
1000 PMNs/mL were subjected to an additional Dynabead separation step
prior to use in assays. Sperm fractions with PMN contamination greater than
1000 cells/mL were discarded.
CASPASE ACTIVITY ASSAYS
Three separate conditions designed to stimulate an apoptotic response
were tested with sperm fractions. After sperm fractions were purified through
Percoll™ isolation and anti-CD45 antibody conjugated paramagnetic bead
depletion of contaminating leukocytes, fractions were divided equally between
four treatments. Staurosporine (S-5921, Sigma, St. Louis, MO), a well-known
protein kinase inhibitor and inducer of apoptosis, was incubated in one sperm
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fraction for four hours. Staurosporine was dissolved and diluted in DMSO to a
concentration of 10 mM. Final concentration in test samples was 10 pM.
A second treatment utilized two equivalent anti-FAS antibodies (Clones
CH-11 and IPO-4, Kamiya Biomedical Company, Seattle, WA) demonstrated
to induce apoptotic responses in somatic cells. Both antibodies were
demonstrated to induce apoptosis in human neutrophils in caspase activity
assays before use in experiments on sperm. Final antibody concentrations in
sperm fractions were 1 pg/mL. As with the staurosporine treatment,
incubations spanned four hours.
Finally, hydrogen peroxide treatment was included in an attempt to induce
apoptosis as a result of oxidation stress or damage. Peroxide concentrations
were 200 pM with a four-hour incubation.
A fourth aliquot was a control aliquot consisting of a sperm suspension
only, also incubated for a period of four hours. Upon completion of the
incubation, each aliquot was evaluated for sperm concentration, motility, using
the Hamilton-Thorne CASA and viability.
Sperm fractions (20-50 x 106 total spermatozoa) were centrifuged to a
pellet for 10 minutes at 325 xg and disrupted in a lysis buffer containing 10
m.M potassium phosphate, 5 mM K2HP04, 5 mM KH2P04, 1 mM EDTA, 10
mM dithiothreitoi (DTT), and 0.5% Triton with pH adjusted to 6.9. Additionally,
the lysis buffer solution contained the general protease inhibitors
phenylmethanesuifonyl fluoride (PMSF), leupeptin, and pepstatin
(Parvanthenani etal., 1998). To aid in protein extraction, the sperm
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suspension was sonicated Sonication periods were kept brief and the
sample was frequently returned to an ice bath to prevent conditions that could
lead to denaturation of enzymes. Following sonication, suspensions were
centrifuged at 16000 xg at 4° C for 10 minutes to remove insoluble particulate
matter. Supernates were removed as close to the pellet as possible while
taking care not to disturb the pellet. Aliquots were stored frozen for no more
than 7 days at >70° C prior use in caspase activity assays.
Upon thawing, an aliquot of sperm lysate was diluted with a solution
containing ICE buffer (50 mM HEPES, 10% sucrose, 0.1% CHAPS, pH 7.5)
and the fluorogenic substrate Ac-DEVD-afc (N-acetyl-aspartate-glutamatevaline-aspartate-AFC, 7-amino-4-trifluoromethyl coumarin) (Parvathenani, et
al., 1998). Fluorescent emission (excitation 400 nm and emission 505 nm)
was measured after incubation for 45 minutes at 37s C. Fluorescence without
sperm was evaluated to determine background status. Samples containing
7.813,15.625, 31.25, 62.5,125, 250, and 500 pmol AFC (7-amino-4trifluoromethyl coumarin) were prepared as standards to determine the
amount of fluorochrome released. These standards were used to generate
standard curves from which enzymatic activity was derived. Sperm lysates
were evaluated in duplicate. Each sample contained 195 pL ICE buffer, 25 pl
ot DTT solution (15mg/mL), 10 pL of 2.5 mM Ac-DEVD-AFC, and 20 pL sperm
lysate. Reaction mixtures were incubated in the dark for 45 minutes in a 37°
C incubator with a 5% CO^in 100% humidified room air atmosphere.
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Fluorescence was measured at Xmax= 505 nm using a SpectraMax Gemini
XS (Molecular Devices, Sunnyvale, CA). Caspase activity was expressed as
femtomole (fmol)/min/106 cells and picomole (pmol)/min/mg protein. Human
neutrophils treated with 1 mM cycloheximide (to induce apoptosis) were used
as positive controls. The level of sensitivity of this assay was determined to
be 250,000 cells using standard curves of caspase activity in known numbers
of neutrophils, Jurkat cells and HL-60 cells.
PROTEIN ASSAYS
Protein assessment for caspase assays was performed using the Bio-Rad
Protein Assay (Bio-Rad). This colorimetric assay is a microplate modification
of the Bradford method (Bradford 1976). Bovine serum albumin (BSA) was
used to prepare standards. BSA standards were serial dilutions of 1 mg/mL
H2O stock solutions. Protein standards were: 1, 0.5, 0.25, 0.125, 0.0625, and
0.03125 mg/mL. Protein dye was diluted 1:5 with deionized HaO prior to use.
Protein concentrations were performed in 96-well micro-titer plates (Corning).
For each sample, 200 pL of the diluted protein dye was added to each well.
Cell lysates with unknown protein concentration were diluted at least 1:3 prior
to mixing with the protein dye. To the protein dye mixture was added 5 pL of
each sample. Protein concentrations were measured on a Tecan Spectra
Micro-Titer Plate Reader with 595 nm filters.
PROTEIN IMMUNOBLOTS
Protein immunoblot analysis was performed on dedicated aliquots of both
high motility and tow motility sperm fractions. Sperm fractions were
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centrifuged at 325 xg for 10 minutes, the supernate discarded and the pellet
resuspended in PBS. This procedure was repeated twice. After the second
centrifugation step, 5x electrophoresis sample buffer was added directly to the
pelleted sperm. The pellet was resuspended by pipetting thoroughly through
an Eppendorf pipet tip. It was necessary, in certain instances, to force highly
viscous mixtures through a 23-gauge (hypodermic) needle to reduce the
viscosity. Reconstituted samples were then boiled for 10 minutes at 95° C.
Samples were either immediately used for gel electrophoresis or frozen at 20° C until use in SDS-polyacrylamide gel electrophoresis (SDS-PAGE).
Discontinuous polyacrylamide gel electrophoresis was used in all
experiments. Stacking gels in each experiment were 4% acrylamide.
Resolving gels ranged from 6.3% to 14% acrylamide, with the latter being
most useful for most applications. In cases where protein digestion products
of interest were close in molecular weight to undigested proteins,
concentrations of acrylamide were adjusted to allow for resolution of distinct
breakdown products.
Gels were cast using a Bio-Rad Mini-Protean 3 Electrophoresis System
(Bio-Rad Laboratories, Hercules, CA) casting apparatus (catalog 165-3301.
Prior to casting glass plates were thoroughly cleaned, rinsed with deionized
water, and dried. Glass plates with integral 0.75 mm spacers and 10 well
combs were used. During polymerization, the resolving gel was overlayered
with a 0.5% SDS in ultrapure water. When polymerization of the resolving gel
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was complete, the SDS overlay was carefully removed and the stacking gel
was added. A 10 well comb was used when casting the stacking gel.
When polymerization was complete, the gels were mounted in a Bio-Rad
Mini-Protean III electrophoresis tank. Electrophoresis was performed at 200V
until the dye front from the samples was running uniform, then the voltage was
reduced to 150V for the remainder of the electophoresis. Electrophoresis was
stopped when the dye front reached a point within 0.5 cm of the bottom of the
gel.
Gels were removed from the electrophoresis tank and glass support
plates. Stacking gels were separated and resolving gels were soaked in
transfer buffer (39 mM glycine, 48 mM Tris base, 0.037% SDS, and 20%
methanol) for 30 minutes. Ten minutes prior to transfer PVP electrophoresis
membranes and blotting paper were cut to slightly larger dimensions than the
gel size and soaked in transfer buffer. PVP membranes required a short rinse
with methanol followed by transfer buffer prior to use.
A Bio-Rad SD Semi-Dry Transfer Cell (Bio-Rad) was used for transfers.
Blots were assembled in order with blot paper, membrane, gel, and a second
blot paper. Care was taken to prevent or reduce the incidence of air bubbles
that could retard efficient transmission of proteins from the gel. Protein
transfer was earned out for approximately 20-30 minutes to ensure complete
transmission. The apparatus was disassembled and remaining protein
binding sites on the membrane were blocked for one hour at room
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temperature under constant agitation. The blocking agent was 5% non-fat dry
milk in wash buffer (10 mM Tris base, 100 mM NaCI, and 0.1% Tween-20).
PRIMARY ANTIBODIES
Primary antibodies were chosen for major apoptotic markers in somatic
cells. All antibodies were obtained from B-D Pharmingen Antibodies were:
polyclonal anti-caspase-3, anti-caspase-7, anti-caspase-9, anti-poly-ADPribose polymerase (PARP), and anti-BID. BD Pharmingen mouse anti-human
caspase-7 monoclonal antibody 551237 was used to assay for the presence
of caspase-7 in sperm. The antibody detects the unmodified procaspase-7 at
35 kDa, the intermediate form at 32 kDa, and the 20 kDa subunit of the active
enzyme. Purified rabbit anti-caspase-9 polyclonal antibody 550437, also from
BD Pharmingen was used to assay for the presence and activation of
caspase-9. The procaspase-9 enzyme is processed from a 48 kDa inactive
form into 37 kDa large and 10 kDa small subunits. BD Pharmingen mouse
anti-PARP [Poly (ADP-ribose) Polymerase] monoclonal antibody 65196E was
used to assay for the presence and inactivation of this chromatin-associated
enzyme. The 116 kDa intact enzyme is processed by caspases-3 and -9 into
85 kDa and 25 kDa inactive fragments. Anti-Apoptosis Inducing Factor (AIF)
rabbit polyclonal antibody (NT) X1109P was obtained from Exalpha
Biologicals, Incorporated (Boston, MA) and detects the 67 kDa AIF protein.
Becton-DiCkinson Pharmingen rabbit anti-BID polycfonal antibody 550365 was
used to detect the presence of this 24 kDa Bcl-2 family member. The
antibody recognizes full-length BID as well as the active 15 kDa cleaved form.
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Primary antibody incubation began with addition of fresh blocking buffer
and the addition of the primary antibody so that the adjusted concentration of
antibody was 1:1000 dilution. Primary antibody incubation was continued with
gentle agitation overnight.
Upon completion of incubation with primary antibody, blots were washed
for three consecutive ten-minute periods with wash buffer prior to addition of
the secondary antibody. An appropriate secondary, peroxidase conjugated
secondary antibody was used for visualization of the labeled protein bands.
The blots were incubated with the secondary antibody for two hours at room
temperature with gentle agitation. As a final step prior to filming, blots were
washed three additional times at ten-minute intervals in fresh wash buffer.
ECL western blotting detection kits (Amersham Pharmacia Biotech,
Piscataway, NJ) were used to visualize the protein bands. The two part
developing solution was mixed in equal aliquots just prior to filming. The
resulting chemiluminescence bands were recorded on Hyperfilm ECL films
(Amersham Pharmacia, Piscataway, NJ) and developed. The position of
labeled protein bands relative to molecular weight markers allowed
identification of proteins and their condition (e.g., either active or inactive in
the case of enzymes).
CASPASE-3 IMMUNOFLUORESCENCE
Semen samples selected forcaspase-3 immunofluorescence were
washed twice with PBS to remove seminal fluid. Sperm concentrations were
adjusted to 1 million/mL. For these samples, no effort was made to deplete
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non-spermatogenic round cells from the processed samples. The presence of
PMNs in the suspension was actually desirable since these cells provided
positive controls when apoptotic. Twenty-five pL of the adjusted sperm
suspension was placed on a poly-L-lysine coated microscope slide. The
samples were immediately diluted with 25 pL of 4% paraformaldehyde
(Sigma, St. Louis , MO) in PBS for fixation. Cells were fixed for a minimum of
10 minutes. During this time, sperm settled to contact the slide. After fixation
the aqueous phase was removed by touching one edge of the drop with a
Kim-Wipe™ (Fisher Scientific, Pittsburgh, PA). The remaining fluid was
allowed to dry and the slide was stored at -70° C until evaluation.
Just prior to evaluation, slides were removed and washed three times with
25 pL PBS. Non-specific binding of primary antibody was prevented by a
single 1 hour incubation in 25 pL of blocking buffer containing 10% normal
goat serum (NGS) in PBS. The primary antibody, anti-active caspase-3 (BD
Pharmingen 559565), was mixed with incubation buffer at 10 pg/mL. Spots
containing sperm were incubated for one hour at room temperature with 25 pL
of primary antibody solution. Spots were washed three times with wash
buffer. The secondary antibody, a fluorescein isothiocyanate (FITC)
conjugated goat anti-rabbit polyclonal antibody (Pharmingen 554020), was
diluted at a 1:200 ration with incubation buffer. After one hour, the spots were
once again washed three times with wash buffer. After the final wash, the
spots were drained and 3 pL of an anti-bleaching agent anti-quench was
added. Slides were immediately coverslipped and evaluated using a Nikon
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Eclipse E600 stereo microscope with a Y-FL epifluorescence attachment
(Nikon, Melville, NY). At least 200 cells were evaluated per sample. Images
were recorded using a Spot RT Slider digital camera (Spot Diagnostic
Instruments, Inc, Sterling Heights, Ml) using Spot RT version 3.2 software
attached to a Gateway Pentium 4 computer.
FLOW CYTOMETRY
Recombinant FITC conjugated Annexin-V (human) catalog 209-250-T300
was obtained from Alexis Biochemicals (Alexis Corporation, San Diego, CA).
High and low motility sperm fractions were separated from whole semen using
Percoll™, immunodepleted using anti-CD45 conjugated paramagnetic beads,
and separated into control and treatment fractions. Each sperm fraction was
incubated in their respective treatment group for four hours prior to flow
cytometry. Treatment included 10 pM STS, anti-Fas antibody, and 200 pM
H2O2. Fraction concentrations were adjusted for a total 1 x 106 sperm.
Upon completion of incubation, sperm fractions were centrifuged to a pellet
in a microcentrifuge (Eppendorf), the supernate discarded and the pellet
resuspended. Each sample was washed twice in PBS. After the final wash,
pelleted sperm were resuspended in 195 pL sterile-filtered Annexin-V binding
buffer (10 mM Hepes/NaOH, pH 7.4,140 mM NaCI, 2.5 mM CaCI2l). A dual
labeling method was used to distinguish ceirs in which PS translocation had
occurred from necrotic cells (Lagarkova etal., 1995). FITC labefed Annexin-V
was used to detect PS on the outer leaflet of the plasma membrane. Necrotic
cells were labeled using ethidium homodimer-1. To the cell suspension was
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added 5 |iL of Annexin-V-FITC. As a viability counter-stain, a 1

solution of

ethidium homodimer-1 (Molecular Probes, Eugene, OR) was used.
Suspensions were well mixed and allowed to stand in the dark for 10 minutes
at room temperature. After incubation with Annexin, an additional 190 |xL of
binding buffer was added and 10 pL of 1mM ethidium homodimer-1 in OMSO
was added to the each suspension. Sperm suspensions were evaluated on a
Becton-Dickinson FACalibur bench-top flow cytometer (Becton-Dickinson, San
Jose, CA) through excitation with a 15 milliwatt 488 nm air-cooled argon-ion
laser.
For each suspension, 15,000 sperm were analyzed for Annexin-V binding
and/or ethidium homodimer uptake. Emission data were collected and
analyzed using CellQuest (Becton-Dickinson, San Jose, CA). Three different
types of binding could be observed: Annexin-V only (indicates cells with PS
translocation to the outer membrane leaflet), ethidium homodimer only binding
(cells with compromised membranes), and cells labeled with both Annexin-V
and ethidium homodimer. Cells displaying both Annexin-V and ethidium
homodimer labeling were considered necrotic due to the possibility that
Annexin binding could be occurring on the inner membrane leaflet.
STATISTICAL ANALYSIS
Viability data were transformed and analyzed using analysis of variance
(ANOVA). Results of caspase activity assays were compared using
Generalized Estimating Equations analysis. Flow cytometry data was
analyzed by rank transformation percentages of cells in each of three groups
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(Annexin-V bound live cells, unlabeled live cells, and necrotic cells) from
contour plots of the data. The transformed data was then analyzed using
single factor analysis of variance (ANOVA) with post-hoc multiple
comparisons tests.
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CHAPTER III
RESULTS
CASPASE ACTIVITY ASSAYS
Sperm motion parameters were analyzed to evaluate associations
between motility and caspase activity. Motion parameters analyzed were
VAP, VSL, VCL, ALH, BCF, STR, LIN, RAPID, MEDIUM, SLOW, and STATIC
(Table 1). Motion parameters in semen, high motility, and low motility were
not significantly different between patients and donors. In high motility
fractions control and Fas antibody treated samples were not significantly
different in any motion parameter after four hours of incubation. Treatment
with H2O2 resulted in complete loss of motility. Staurosporine treatment also
resulted in significant decrease (to nearly zero) in every motility parameter
examined. In staurosporine-treated fractions, sperm motility typically was
limited to twitching, non-progressive types of movement with occasional
sluggish, forward progression in very few sperm.

Table I. Motility Parameters
Abbreviation
VAP
VCL
VSL
STR
LIN
BCF
Rapid
Medium
Slow
Static

Parameter
Average path velocity (pm/s)
Path velocity (pm/s)
Straight line velocity (pm/s)
VSL/VAP x 100
VSL/VCLx 100
Cross beat frequency (Hz)
VAP greater than 25 pm/s
5 pM/s < VAP < 25 pm/s
Less than 5 pm/s
Non-moving
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Caspase activity was significantly and negatively correlated to VAP, VSL,
and BCF in Fas antibody treated samples. Caspase activity decreased 1.91
pmol/min/mg protein for every percent increase in VAP, 2.5 pmol/min/mg
protein for every percent increase in VSL, and 8.44 pmol/min/mg protein for
every percent increase in BCF.
In staurosporine-treated fractions, caspase activity expressed in
pmol/min/mg protein was significantly and positively correlated to medium and
slow parameters. Caspase activity increased 43.68 pmol/min/mg protein for
every percent increase in medium and 20.52 pmol/min/mg protein for every
percent increase in slow motion parameters.
When analyzing caspase activity expressed as fmol/min/106 cells, activity
was significantly and positively related to ALH in staurosporine-treated
fractions. Caspase activity increased 37.52 fmol/min/106 cells for every unit
increase in ALH. Additionally, two associations of marginal significance were
noted. For Fas antibody treated fractions, caspase activity decreased 25.82
fmol/min/106 cells (p=0.059). In staurosporine-treated fractions, caspase
activity increased 5.21 fmol/min/106 cells for every unit increase in linearity
(p=0.056). Table 2 details correlations and significance between motility
parameters and caspase activity.
Morphology results were evaluated to determine association with caspase
activity. No correlation between caspase activity and morphology percent
normal sperm could be made. In patient low motility fractions regardless of
activity units, caspase activity increased with increasing cytoplasmic droplets,
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but decreased in high motility fractions (p=0.031 for pmol/min/mg protein;
p=0.01 for fmol/min/106 cells). In donors, no significant change in caspase
activity was detected with the presence of cytoplasmic droplets, although
trends followed the same pattern seen in patients. H2O2 treated fractions had
significantly lower viability than any other treatment group.

Table II. Correlations Between Motility and Caspase Activity
Parameter
VAP

Treatment

Control
Fas
STS
VSL
Control
Fas
STS
VCL
Control
Fas
STS
ALH
Control
Fas
STS
BCF
Control
Fas
STS
Linearity
Control
Fas
STS
Rapid
Control
Fas
STS
Medium
Control
Fas
STS
Slow
Control
Fas
STS
Static
Control
Fas
STS
"Significant correlations

Correlation with Caspase Activity
pmol/min/mg protein
fmol/min/10 sperm
-0.103 (0.615)
-0.271 (0.181)
-0.521 (0.038)*
-0.387 (0.125)
0.154(0.516)
0.229 (0.332)
-0.078 (0.705)
-0.261 (0.198)
-0.517(0.040)*
-0.348 (0.171)
0.341 (0.141)
0.184(0.437)
-0.220 (0.280)
-0.099 (0.629)
-0.443 (0.075)
-0.350 (0.183)
0.187 (0.429)
0.150 (0.529)
-0.005 (0.982)
-0.033 (0.871)
-0.115(0.672)
-0.467 (0.059)
0.503 (0.024)*
0.201 (0.396)
-0.128 (0.396)
-0.023 (0.913)
-0.065 (0.806)
-0.687 (0.003)*
0.154(0.517)
0.088 (0.712)
0.018 (0.932)
-0.165 (0.419)
0.182(0.485)
-0.187 (0.488)
0.434 (0.056)0.065 (0.784)
-0.340 (0.089)
-0.039 (0.849)
-0.358 (0.158)
0.232 (0.388)
0.106 (0.657)
0.405 (0.077)
-0.170 (0.406)
0.091 (0.660)
0.280 (0.294)
-0.063(0.811)
0.381 (0.097)
0.637 (0.003)*
0.012 (0.952)
-0.021 (0.919)
-0.054(0.837)
0.286 (0.283)
0.374(0.104)
0.508 (0.022)*
0.323 (0.107)
0.029 (0.887)
0.337 (0.186)
-0.258 (0.335)
0.383 (0.096)
0.004(0.988)
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Viability evaluation was performed at the completion of each four-hour
treatment cycle. Percent viable sperm in anti-Fas antibody staurosporinetreated fractions did not differ significantly from control fractions in either high
or low motility fractions (Table 3). This indicated a negligible toxicity effect of
these two treatments upon sperm viability. The H20 2 treatment resulted in
profound toxicity, significantly lower than corresponding control values. In
comparisons of patients and donors responses, patient high motility H20 2treated fractions had significantly higher (p<0.001) viability than matched
donor fractions.

Table III. Viability in High and Low Motility Fractions
Fraction
High Motility
Control
Fas
h 2o 2
Staurosporine

Patient

n

Donor

n

78.4 ±3.7
69.7 ±7.0
16.0 ±3.0
77.0 ±3.5

21
10
101
19

84.3 ±2.6
81.0 ±4.9
3.8 ± 0.93
79.0 ±4.9

8
8
8
8

Low Motility
Control
Fas
H20 2
Staurosporine

40.9 ±3.8
43.5 ±4.1
10.5 ±4.5
41.9 ±3.2

16
11
4*
12

58.3 ±19.3
51.7 ±9.2
5.4 ±2.14
76.3 ±9.3

8
6
5
4

—r rHigh
r Motility Control vs. H20 2.- z*P=0.037
s rr
'p= 0.001 Patient
Patient Low Motility
Control vs. H20 2. 3P<0.001 Donor High Motility Control vs. H20 2. 4P<0.001
Donor Low Motility Control vs. H2Q2.

Caspase activity was expressed in pmol/min/mg protein and fmol/min/106
cells. Early experimental results demonstrated variability in protein
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concentrations of sperm fractions containing identical number of cells. The
possibility of interference from components of the lysis buffer was explored.
The lysis buffer contained Triton X-100 to facilitate solubilization of cellular
proteins. Bradford (1976) demonstrated that Triton X-100 and other strong
alkaline buffering agents (sodium diodecyl sulfate, SDS, and commercial
detergents) interfere with the protein dye-binding assay that he championed
and lead to significant error in protein determination. The error effect of trace
amounts of these compounds could be corrected by appropriate controls.
However, in higher concentrations, the interference from these chemicals is
insurmountable. In order to determine the level at which the lysis buffer
interfered with the dye binding, lysis buffer was serially diluted with ICE buffer
in ratios 1:5,1:4,1:3,1:2, and undiluted (Graph 1). Interference from Triton
X-100 began to be detectable in dilutions less than 1:3 and was clearly
pronounced at 1:2 dilutions. Undiluted lysis buffer caused protein
measurements to be inflated far above the actual concentration. Due to the
small amount of protein in most sperm fractions, it was necessary for dilutions
to be a maximum of 1:3. A 1:3 dilution, for most fractions, would bring protein
concentration into the lowest reliably detectable range based on standard
curves. Dilutions of 1:2 would have solidly placed protein concentrations on
the curve. To avoid the pitfall of lysis buffer interference in protein
determinations, an alternative expression o f caspase activity was found in
expressing activity in units/106 sperm. It is believed that the fmol/min/106
sperm is a more reliable figure than pmol/min/mg protein.
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0.5
0.4
0.3
0.2
0.1
1:5

1:4

1:3

1:2

No Dilution

Lysts Buffer Dilution

Graph 1. Lysis Buffer Interference With Protein Assays.

Control and three treatment fractions (Fas antibody, staurosporine, and
H2O2) were compared for caspase activity. For patient high motility fractions
expressed as pmol/min/mg protein, there were 25 control, nine Fas antibody,
twelve H2O2 , and twenty-one staurosporine-treated fractions. When caspase
activities were expressed as fmol/min/106 cells, the number of replicates was
the same with the exception of Fas antibody treated fractions that increased to
ten replicates. For donor fractions, nine control, eight Fas antibody, eight
H2O2, and nine staurosporine fractions were analyzed for both pmol/min/mg
protein and fmol/min/106 cells.
In order to determine whether caspase activity could be induced, caspase
activities were compared first between control and treatment groups.
Comparisons were then made between both control and treated donor and
patient fractions. Other analyses involved comparing high and low motility
fractions for both control and treatment groups.
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When results were expressed in pmol/min/mg protein, no significant
difference was detected in patient high motility fractions between the control
(n=25) and any of the three treatment groups (Table 4 and Graph 2). In low
motility fractions, caspase activity for H20 2 fractions were significantly lower
(p=0.021) than corresponding control fractions (Graph 3). Staurosporinetreated fraction had significantly higher (p=0.039) caspase activity than
corresponding Fas antibody treated fractions. However, there were no
significant differences between control and Fas antibody treated fractions.

Table IV. Patient Caspase Activities (pmol/min/mg protein)
Fraction
High Motility
Control
Fas Antibody
h 2o 2
Staurosporine

Caspase Activity1
pmol/min/mg protein

n

78.8 ±22.9
101.0 ±50.3
84.4 ±23.3
119.7 ±34.7

25
9
12
21

Low Motility
Control
72.8 ±21.8
Fas Antibody
59.1 ± 27.02
h 2o 2
54.1 ±16.2
Staurosporine
72.4 ±30.7
Values are means ± SEM. ZF=0.039 compared with Fas antibody.
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Graph 2. Caspase Activity In Patient High Motility Fractions. No significant
differences. Values are means ± SEM.
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Graph 3. Caspase Activity In Patient Low Motility Fractions. *P=0.021, H2O2
caspase activity was lower compared with control. #P=0.039, staurosporine
was higher compared with Fas antibody treated fractions. Values are means
±SEM.
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Comparisons between high and low motility fractions were also done.
When comparing controls high and low motility, caspase activities were
comparable. Of the remaining two treatment groups, Fas antibody and
staurosporine treated fractions demonstrated no significant differences
between high and low motility fractions (Graph 4). H2O2 treated high motility
fractions had significantly higher (p=0.009) caspase activity than low motility
fractions (Table 5).

Table V. Patient Baseline Caspase Activities (pmol/min/mg protein)
Caspase Activity1
pmol/min/mg protein
72.8 ±21.8
78.8 ±22.9

Fraction
Low Motility
High Motility
1Values are means ± SEM.

n
18
25

180
160
e 140

NS

«

0 120
a 100

1

80

^

60

i*

40
20

0
High Motility

Low Motility

Graph 4. Patient Caspase Activities in STS Fractions. NS: No significant
differences. Values are means ± SEM.
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Sperm fractions from donors were compared in a similar manner. With
high motility fractions, two (Fas antibody and H20 2) of the three treatment
groups did not significantly differ from control fractions. Staurosporine-treated
fractions, however, had significantly higher (p<0.001) (Graph 5) caspase
activities than control fractions and was also significantly higher than either
Fas antibody (p=0.005) or H20 2 (p=0.043) treated fractions (Table 6).
In low motility fractions and with the exception of the H20 2 treated
fractions, none of the treatments were significantly different from the control
fractions (Graph 6). The H2O2 treated fractions had significantly lower
caspase activity than corresponding control fractions.

Table VI. Donor Caspase Activities (pmol/min/mg protein)
Fraction
High Motility
Control
Fas Antibody
H20 2
Staurosporine

Caspase Activity1
pmol/min/mg protein

n

18.8 ±7.5
19.9 ±6.0
24.4 ±8.6
41.6 ± 9.72

9
8
8
9

Low Motility
Control
32.0 ±8.8
Fas Antibody
33.1 ±7.6
h 2o 2
9.7 ± 5.82
Staurosporine
51.1 ±17.3
Values are means ±SEM.
2P<0.001 lower caspase activities compared with Control fractions.
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Graph 5. Donor High Motility Fractions (pmol/min/mg). *P<0.001 compared
with matched control fractions. Values are means ± SEM.
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Graph 6. Donor Low Motility Fractions (pmol/min/mg). No significant
differences. Values are means ± SEM.

Comparisons between high and low motility fractions detected significantly
higher (p=0.049) caspase activities in low motility control fractions compared
with high motility fractions (Table 7).
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Table VII. Donor High and Low Motility Fraction Caspase Activities
Fraction
Low Motility
High Motility
Values are means ± SEM.
ZP=0.049.

Caspase Activity1
pmol/min/mg protein
32.0 ±8.8
18.8 ±7.52

n
9
9

Donor and patient samples were compared (Tables 8 and 9) to distinguish
whether caspase activity in donors were different than patients* Comparisons
were first made with caspase activities expressed in pmol/min/mg protein
between donors and patient high and low motility control, Fas antibody-,
staurosporine-, and H20 2-treated fractions* High motility fractions from
patients had significantly (p=0.012) higher caspase activities than control
(Graph 7), staurosporine (p=0.029, Graph 8), and H20 2-treated fractions
(p=0.030). No other significant differences were detected between patient
and donor sperm fractions.
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Table VIIL Donor and Patient High Motility Caspase Activities
Fraction
Control
Patients
Donors
Fas Antibody-Treated
Patients
Donors
Staurosporine-Treated
Patients
Donors
H2O2-Treated
Patients
Donors
Values are means ± SEM.

Caspase Activity1
pmol/min/mg protein

P-value

78.8 ±22.8
18.8 ±7.0

0.012

89.2 ±58.7
16.6 ±5.4

0.218

122.9 ±36.2
41.6 ±9.2

0.029

77.5 ±23.8
22.8 ±8.2

0.030

120

e
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a
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|

i
o
E
a.

60
40

*

20

Patients

Donors

Graph 7. Patient and Donor High Motility Sperm (pmol/min/mg). *P=0.012.
Values are means ± SEM.
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Graph 8. Patient and Donor High Motility STS (pmol/min/mg). *P=0.029.
Values are means ± SEM.

Table IX. Donor and Patient Low Motility Caspase Activities
Fraction
Control
Patients
Donors
Fas Antibody-Treated
Patients
Donors
Staurosporine-Treated
Patients
Donors
H20 2-Treated
Patients
Donors
Values are means ± SEM.

Caspase Activity1
pmol/min/mg protein

p-value

72.8 ±21.6
32.0 ±8.3

0.078

58.6 ±27.4
29.3 ±6.8

0.309

78.2 ±31.6
50.7 ±17.5

0.448

11.6 ± 5.7
6.5 ±4.8

0.490

Because of concerns about protein measurement, caspase activity was
also measured in fmol/min/106 cells. An advantage of this method of caspase

i
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measurement is that it eliminates the necessity of performing protein
measurements on samples and error that could be introduced as a result of
using these measurements.
In high motility fractions from patients, only the staurosporine treatment
group had significantly higher caspase activities (p=0.003) than the control
fractions (Table 10 and Graph 9). The staurosporine fractions also differed
significantly from Fas antibody- (p=0.003) and H20 2-treated fractions
(p=0.039). No differences were detected among low motility fractions (Graph
10).

Table X. Patient High Motility Fraction Caspase Activities
Caspase Activity1
fmol/min/106 cells
151.5 ±28.4
109.1 ±28.8
324.5 ±110.9
378.4 ±85.32

Fraction
Control
Fas Antibody
H2O2
Staurosporine
iw

n
25
10
12
21

7

2Staurosporine fractions were significantly (P=0.003) higher than Control
fractions, Fas antibody treated (p=0.003), and H20 2 treated (P=0.039)
fractions.
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Graph 11. Patient STS Treated (fmol/min/106 Cells). No significant
differences. Values are means ± SEM.

Table XI. Patient Low Motility Caspase Activities
Caspase Activity1
fmol/min/106 cells
Control
195.4 ±83.3
Fas Antibody
101.3 ±33.3
H2O2
98.9 ±37.3
Staurosporine
68.8 ±48.0
u,
...
Values are means ± SEM. No significant comparisons.

Fraction

n
18
11
4
14

For patients, no differences were detected between high and low motility
control fractions (Table 12) and high and low motility Fas antibody-treated
fractions. High motility H2O2 treated fractions had significantly higher
(p=0.016) caspase activities compared with low motility fractions. High motility
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staurosporine-treated fractions were significantly higher (p=0.004) than low
motility fractions (Graph 11).

Table XII. Patient High and Low Motility Baseline Caspase Activities
Caspase Activity1
fmol/min/106 cells
Low Motility
195.4 + 83.3
High Motility
151.5+28.4
Values are means + SEM. No significant differences.

Fraction

n
18
25

In donor sperm fractions, no significant differences were detected between
high motility control fractions and either Fas antibody or H2O2 treatments
(Table 13). Staurosporine-treated fractions were significantly higher than
control (p<0.001) and Fas antibody (p=0.016) treated fractions (Graph 12).
No comparison between low motility control, Fas antibody, H2O2 , and
staurosporine fractions were significantly different (Graph 13).
Donor high and low motility control fractions were not significantly different
in caspase activities (Table 14). Comparisons between high and low motility
Fas antibody treated fractions revealed significantly higher (p=0.023) caspase
activities in the low motility fraction. Both H2O2- and staurosporine-treated
high and low motility fractions had comparable caspase activities. Caspase
activities were lower, but not significantly so, in low motility H2O2 fractions
compared with high motility fractions in the same treatment group. Caspase
activities in staurosporine-treated high and low motility fractions were nearly
identical.
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Table XIII. Donor High Motility Fraction Caspase Activities
Caspase Activity1
fmol/min/106 cells

Fraction

n

High Motility
Control
9
67.8 ±22.5
Fas Antibody-Treated
8
66.9 ±23.8
H20 2-Treated
8
108.4 ±40.4
Staurosporine-Treated
9
155.4 ± 34.32
Low Motility
Control
9
133.3 ±32.0
Fas Antibody-Treated
6
150.2 ±27.9
H20 2-Treated
5
53.9 ±48.6
Staurosporine-Treated
5
198.1 ±42.3
Values are means ± SEM. zStaurosporine-treated fractions were significantly
(p<0.001) different compared with Control fractions and Fas antibody treated
(p=0.016).
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Graph 12. Donor High Motility (fmol/min/106 Cells). *P=0.001. Values are
means ± SEM.
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Values are means ± SEM.

Table XIV. Donor High and Low Motility Baseline Caspase Activities
Fraction
Low Motility
High Motility
Values are means ± SEM.

Caspase Activity1
fmol/min/106 cells
133.3 ±32.0
67.8 ±22.5

n
9
9

When comparing patient and donor high motility control fractions (Graph
14), patient fractions had significantly higher (p=0.02) caspase activity than
donor fractions (Table 15). No significant difference was detected between
low motility patient and donor fractions. Patient staurosporine-treated
fractions had significantly higher (p=0.016) caspase activities that were nearly
two and one-half times higher than donor fractions (Graph 15). Conversely,
no significant difference was detected between low motility patient and donor
staurosporine-treated fractions (Table 16). No statistically significant

I
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difference was detected in comparisons between either high or low motility
fractions in Fas antibody or H20 2 treatment groups.

Table XV. Donor and Patient High Motility Fractions Caspase Activities
Fraction
Caspase Activity1
p-value
■
________________________ fmol/min/106 cells_____________
Control
Patients
0.02
151.5 ±28.8
Donors
67.8 ±21.8
Fas Antibody
Patients
0.258
109.1 ±29.0
Donors
66.9 ±23.6
Staurosporine
0.016
Patients
378.5 ±86.2
Donors
155.4 ±33.4
h 2o 2
Patients
0.069
324.5 ±111.9
Donors
108.4 ±27.1
Values are means ± SEM.
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Graph 14. Donor and Patient High Motility (fmol/min/106 Ceils). *P=0.002.
Values are means ±SEM.
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Table XVI. Donor and Patient Low Motility Fractions Caspase
Activities
Fraction
Caspase Activity^
p-value
____________________________ fmol/min/108 cells__________
Control
Patients
0.489
195.4 ±84.1
Donors
133.3 ±31.3
Fas Antibody-Treated
Patients
0.258
109.1 ±29.0
Donors
66.9 ±23.6
Staurosporine-Treated
0.461
Patients
151.6 ±48.9
Donors
198.1 ±40.0
H2O2-T reated
0.802
Patients
68.6 ±36.6
Donors
53.2 ±49.3
Values are means ± SEM. No significant differences.
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PROTEIN IMMUNOBLOTS
CASPASE-3
Caspase-3 is one of three caspases that can give positive reading using
the caspase activity assay. Fractions from 9 donors and 6 patients were
evaluated. Between 20 million and 50 million sperm were necessary to
visualize the inactive, procaspase-3 protein. Thus, this assay was limited to
patients with adequate sperm concentrations. Procaspase-3 (32 kDa) was
demonstrated, to a variable degree, in both high and low motility sperm
fractions from both donors and patients. Active capase-3, however, was
either absent or below the detection limits of the assay. Some very light 17-20
kOa bands were demonstrated in a small minority of samples. Figure 1 is a
representative immunoblot showing only procaspase-3.

1

2

3

4

Figure 1. Caspase-3 Immunoblot All fractions are donor high motility. Lane
t: Untreated. Lane 2: Fas Antibody-treated. Lane 3: STS-treated. Lane 4
Peroxide-treated.
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CASPASE-7
Capase-7 is a second caspase that is capable of cleaving the AC-DEVDAFC substrate used for caspase activity assays. The inactive procaspase-7
typically migrates to approximately 35 kDa during gel electrophoresis. An
intermediate caspase-7 protein migrating to 32 kDa is formed upon cleavage
of the 35 kDa proenzyme. Finally, the active enzyme is composed of 20 and
11 kDa subunits. With fractions from two patients and four donors, the 35
kDa band was readily visible. In low motility fractions from both patients, the
intermediate procaspase-7 band was also observed. Sperm concentrations
greater than 20 x106/mLwere necessary, as with caspase-3 immunoblots. In
some sperm fractions, the intermediate 32 kDa band was also visible. In no
case was either of the component subunits of active enzyme detected. A
representative caspase-7 immunoblot is shown in Figures 2 and 3.
1

2

3

4

5

6

7

45
30

20.1

Figure 2. Caspase-7 Immunoblot. Lane 1: PMNs, untreated. Lanes 2-7,
fractions. Lane 2: High motility STS-treated. Lane 3: High motility untreated.
Lane 4: High motility STS-treated. Lane 5; Low motility untreated. Lane 6:
Low motility STS-treated. Lane 7: High motility untreated.
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Figure 3. Caspase-7 Immunoblot, 7.5% Acrylamide Gel. Lane 1: Jurkat
cells, untreated. Lane 2: Jurkat cells, STS-treated. Lanes 3-9; untreated
sperm fractions. Lane 3: Donor high motility. Lane 4: Patient high motility.
Lane 5: Patient low motility. Lane 6: Patient high motility. Lane 7: Patient
low motility. Lane 8: Patient high motility fraction. Lane 9: Patient low
motility.

CASPASE-9
Caspase-9 is an enzyme involved in apoptosis upstream of caspase-3 in
somatic cells. The inactive, procaspase-9 protein migrates to 46-48 kDa
during SDS-PAGE. Procaspase-9 is processed into a 37 kDa large subunit
and a 10 kDa small subunit in cells undergoing apoptosis. Representative
immunoblots are depicted in Figure 4. Sperm fractions from three patients
and one donor were used for this experiment. As was common with donors
throughout this research, Percoll™ separation resulted in a low motility fraction
with too few sperm for immunoblotting. Two Jurkat cell extracts (4 million
cells) were used as controls. One extract was composed of untreated cells
(lane 1) while in the second (lane 2), Jurkat cells were treated with
staurosporine for four hours. All sperm fractions were untreated Active
caspase-9 was confined to a single patient low motility fraction. No other
fractions exhibited active caspase-9. Some caspase-9 activation was seen in
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the untreated Jurkat cell lysates, although the intensity of the bands were
clearly less than that seen in STS-treated Jurkat cells.
1

2

3

4

5

6

7

8

9

45
30
20.1

Figure 4. Caspase 9 Immunoblot. Lane 1: Jurkat cells, untreated. Lane 2
Jurkat cells, STS treated. Lanes 3-9: untreated sperm fractions. Lane 3:
donor high motility. Lanes 4 ,6 ,8 : patient high motility. Lane 5, 7, 9: patient
low motility.

Poly(ADP-ribose) Polymerase-1 (PARP-1)
Poly(ADP-ribose) Polymerase-1 (PARP-1) typically migrates to 116 kDa
during SDS-Page. In apoptotic cells, PARP-1 is a prime target of caspase-3,
which processes the enzyme to 85 kDa and 25 kDa fragments. No intact
PARP-1 was detected in either sperm or PMNs . The antibody did, however,
react with a 66 kDa protein in every sperm fraction examined. This 66 kDa
band is seen in somatic whole cells extracts and is of cytoplasmic origin.
Immunoblots from 9 donors and 8 patients all exhibited the 66 kDa band and
no other. Since PMNs do not have the PARP-1 enzyme, Jurkat cells were
used as controls. As expected, untreated Jurkat cells displayed a band at
slightly above the 97 kDa band in the expected position of 116-120 kDa
(Figure 5, lane 1). Jurkat cells were stimulated to undergo apoptosis by four
hour incubation with two different anti-Fas antibodies (CH-11 and IPO-4, both
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from Kaimya Biomedical Company, Seattle, WA) and STS. As expected, a
band of approximately 86 kDa was seen (Figure 5, lanes 2,3, and 4). On the
same blot, two sperm fractions (from the same donor, but one as a control
and the other treated with STS) and one PMN extract were evaluated. The
116 kDa PARP-1 band was not detected in any of the three fractions.
However, very faint 66 kDa bands were observed in each fraction.

220

97
66

45
30
Figure 5. PARP-1 Untreated, Staurosporine, and Fas Antibody. Lane 1:
untreated Jurkat cells. Lane 2: CH-11 Fas antibody-treated Jurkat cells.
Lane 3: IPO-4 Fas antibody-treated Jurkat cells. Lane 4: STS-treated Jurkat
cells. LaneS: untreated donor high motility sperm fraction. Lane 6: STStreated donor high motility sperm fraction. Lane 7: STS-treated PMNs.

Figures 6 and 7 are representative of sperm fractions, probed with the antiPARP-1 antibody. In both blots, each sperm fraction exhibited the 66 kDa
band and the complete absence of both the 116 kDa and 85 kDa bands. Two
PMN extracts (one control and one STS-treated fraction) were also evaluated.
Curiously, the untreated PMN extract failed to exhibit even the 66 kDa band
seen in sperm and with STS-treated extracts.

I

-i
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Figure 6. PARP-1 Donor Sperm Untreated and Staurosporine. Lane 1:
STS-treated PMNs. Lane 2: untreated PMNs. Lanes 3-7: sperm fractions.
Lane 3, 6: untreated donor high motility. Lanes 4, 7: untreated low motility.
Lane 5: STS-treated donor low motility.
1

2

3

4

5

6

7

30__ ^
Figure 7. PARP-1 Patient Sperm Untreated and Staurosporine. Lane 1:
STS-treated PMNs. Lanes 2-9: patient sperm fractions. Lanes 2,6: high
motility. Lane 3: STS-treated high motility. Lanes 4, 7: untreated low
motility. Lane 5: STS-treated low motility.

A1F
The presence of Apoptosis Inducing Factor (AIF), a 67 kDa protein
released by mitochondria in response to apoptotic stimuli was evaluated.
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Unlike many of the other apoptotio proteins, AIF does not undergo any
processing and is produced in its active form. For this experiment, 3 patients
and 1 donor were used. In Figure 9, AIF was detected in Jurkat cell controls
as well as sperm extracts from the donor and three infertility patients.

1

2

3

4

5

6

7

8

Figure 8. AIF Immunoblot with Patient Sperm Fractions. Lane 1 Jurkat ceils,
STS-treated. Lanes 2-8: untreated sperm fractions. Lane 2: donor high
motility. Lanes 3, 5, 7: patient high motility. Lane 4, 6, 8: patient low motility.

BID
Like AIF, BID is another important factor in mitochondria regulated
apoptosis. Full-size BID, the inactive form, may migrate to three molecular
weights during SDS-PAGE, 22 kDa, 24 kDa, or 26 kDa. During activation,
BID is primarily processed to a 15 kDa. Minor products have also been seen
at 13 kDa and 11 kDa. In Figure 10, Bid was detected in Jurkat cells, but not
in any of the donor or patient sperm fractions. One donor high motility and
three patient high and low motility fractions were evaluated.
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Figure 9. Bid Immunoblot Lane 1: Jurkat cells, untreated. Lane 2 Jurkat
cells, STS treated. Lanes 3-9: untreated sperm fractions. Lane 3: donor
high motility. Lanes 4, 6, 8: patient high motility. Lane 5,7, 9: patient low
motility.

The effect of four hour H2O2 treatment was studied on sperm fractions was
studied with four H2O2 concentrations, 200 pM, 100 pM, 50 pM, and 25 pM
(Table 17, Graphs 16 and 17). As with data collected during the caspase
activity assays, sperm from a donor semen sample was separated into high
and low motility fractions. Contaminating cells of non-spermatogenic origin
were immunodepleted using the aforementioned paramagnetic method. High
motility fractions incubated with 200 pM had virtually no viable sperm. Motility
was also non-existent for these fractions. The 100 pM fractions displayed
increased viability, although sperm motility was still non-existent. At 50 pM,
viability had reached control values, however, motility was still at or near zero.
At a H2O2 concentration of 25 pM, viability remained at control levels and
progressive motility was noted in some sperm. Findings with low motility
fractions were similar to the high motility fractions (Graphs 18 and 19).
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Graph 18. Low Motility H20 2 Viability Dose Response.
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Table XVIII. Annexin-V Binding in Ethidium Negative Sperm
Fraction
High Motility

Treatment
Control
STS
Fas Antibody
25 pM H20 2
200 pM H20 2

n
10
10
9
4
4

Low Motility

Control
STS
Fas Antibody
25 pM H20 2
200 pM H20 2

8
8
8
4
4

Annexin-V Binding Average ± SEM
2.78 ±0.87
2.98 ±0.69
3.08+0.71
1.69 ±0.82
22.47 ± 6.811
3.96 ±0.69
3.78 ±0.84
4.13 ±1.01
4.06 ±1.06
17.00 ±8.49

1P=0.012 compared with Control fractions. P=0.033 compared with STS
treated fractions. F=0.045 compared with Fas antibody treated fractions.
P=0.012 compared with 25 pM H20 2 treated fractions.
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Graph 20. High M otility Cells With Only Annexin-V Binding. *P=0.012
compared with control fractions.
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Graph 21. Annexin-V Binding In Low Motility Live Cell Populations. No
significant differences. Values are means ± SEM.

Percentages of live and dead (necrotic) cells were not significantly different
from control fractions. Figures 11 is a series of representative contour plots of
flow cytometry data for high and low motility fractions, respectively.
CASPASE-3 IMMUNOFLUORESCENT MICROSCOPY
Nine patients exhibiting severe oligoasthenoteratozoospermia (S-OAT)
were used for caspase immunofluorescence experiments. Of the nine
patients, none had more than 1.2% of the sperm binding. Two patient
samples had no binding. An average of 0.5% of the sperm evaluated
demonstrated active caspase-3.
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8.67%
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7.99%

72.05!
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(b) High Motility 1 jig/mL Fas
Antibody 2 hour incubation.

101
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Annexin-V-FITC Binding

103

(c) High Motility 1 ng/mL Fas
Antibody 4 hour incubation.

Figure 10. High Motility Flow Cytometry Contour Plots. Shown are
representative log density contour plots from Annexin-V flow cytometry studies.
The innermost contour was represented by yellow (50% o f the peak height),
followed by dark blue (25%), orange (12%), light blue (6%), pink (3%), and
green (1%). Annexin-V binding, a maker for PS translocation, was on the xaxis and Ethidium homodimer uptake, a marker for compromised membrane
integrity, was on the y-axis. The percentages in each quadrant were the
percentage o f the total population o f cells exhibiting a labeling pattern. Cells in
the lower left quadrant were normal, live cells with no Annexin-V binding, the
lower right quadrant were cells to which only Annexin-V-FITC was bound
(considered apoptotic in somatic cells), the upper right and upper left
quadrants were necrotic cells as evidenced by ethidium uptake, (a) untreated
control fraction, (b, c) Fas antibody treated 2 and 4 hour incubations. No
significant differences in Annexin-V-FITC binding were observed with
incubation with a Fas antibody.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

70

7.69%

7.86%

13.67%

13.73%

7.80%

-.9.28%

no0

io 1

io 2

Annexfn-V-FITC Binding

104

103

(d) High Motility 10 |iM STS
2 hour incubation.

TO0

Annexin-V-FITC Binding

(e) High Motility 10 uM STS
4 hour incubation.

13.42%

7.57%

40.15%

29.40%

49.69%

102

Annextn-V-FITC Binding

103

(f) High Motility 200 ^M H20 2
2 hour Incubation.

to

°

to 1

io 2

io 3

Annexin-V-FITC 8inding

(g) High Motility 200 jiM H20 2
4 hour Incubation.

Figure 10 (Continued). High Motility Flow Cytometry Contour Plots, (d, e)
STS treated after 2 and 4 hour of incubation. No significant increases were
detected with STS treatment. (fr g) 200 ^M H20 2 after 2 and 4 hours
incubation. Significant increases (P=0.012) in Annexin-V-FITC were detected.
Percentages o f cells binding Annexin-V-FITC increased from 9.4% in untreated
cells to 49.69% at the 2 hour incubation with 200 |iM H20 2. A t 4 hours, fewer
cells were binding Annexin-V-FITC than at 2 hours, however, increases were
still significant over untreated cells. Gradual progression in ethidium uptake
was detected as incubation progressed, indicating increasing numbers of cells
experiencing loss o f membrane integrity.
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Blanc-Layrac study did not use a method of separating non-spermatogenic
cells contaminating semen samples. Since the present study used a method
of separating these cells from sperm, it seems possible the failure to remove
these cells in the Blanc-Layrac study may have contributed to their detection
of both active and inactive PARP-1 proteins.
The 66 kDa band does not match the expected molecular weights of either
the active or inactive form of PARP-1. However, a PARP reactive cytoplasmic
protein of approximately 66 kDa has been noted in whole cell extracts from
somatic cells. The only other human cell that lacks PARP-1 is neutrophils
(Bhatia etal., 1995; Sanghavi eta!., 1998). Bhatia (1995) demonstrated that
intact PARP-1 is missing from non-apoptotic mature human neutrophils and
explored the point during differentiation that immunoreactive PARP-1 is lo st
In the Sanghavi study, and confirmed in the present study (see figure 6, lane
2), both intact PARP-1 was absent from non-apoptotic neutrophils. Given the
highly condensed and therefore inaccessible nature of normal sperm DNA, it
would seem logical that PARP-1 be absent from human sperm.
Selection of the 200 pM H2O2 concentration for use in caspase activity
studies was drawn from a previously published study performed at the Jones
Institute (Duru et al., 2000). in that study, the H2O2 concentration significantly
associated with DNA fragmentation was 200 pM. In somatic cells, caspase
activation, particularly caspase-3 activation, induces a cascade of enzymatic
activity that ultimately culminates in the fragmentation of cellular DNA. The
200 pM H2O2 concentration was tested in the caspase activity assays based
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on the possibility that DNA fragmentation observed at this concentration could
be the result of caspase-dependent apoptotic events in sperm. The
alternative possibility remains that the DNA fragmentation could be the result
of simple, direct oxidative damage to the DNA by H20 2.
It appears from the significantly lower caspase activity seen in H2O2
treated sperm fractions could be explained by the detrimental effect of the
H2O2 concentration on sperm plasma membrane integrity. In sperm with
compromised membranes, the potential exists forcaspases present to diffuse
from the intracellular compartment to the surrounding medium where they
were removed with the supernatant during the concentration process prior to
sonication. H20 2 fractions were the only treatment group with significantly
decreased viability after incubation. This explanation could account for the
dramatically decreased caspase activity in H2O2 treated sperm fractions.
Additionally, H2O2 has been recently shown to inhibit caspase activity
(Borutaite and Brown 2001). Absent the escape of caspases from
compromised sperm membranes, the finding that H2O2 inactivates caspases
could explain the significantly lower caspase activity in fractions treated in this
manner. Significantly, the inhibition of caspase activity was shown to be
reversed by the addition of dithiothreitol (DTT) to the suspension. Given that
the lysis buffer used in preparation of the sperm extracts contained DTT,
makes the explanation o f caspase inactivation by H2O2 unlikely. Therefore, it
appears most likely that, in H2O2 treated fractions, any caspases that may
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have been activated through mechanisms secondary to oxidative stress were
lost due to compromised integrity of the sperm plasma membrane.
Two stimulatory anti-Fas antibody clones (CH-11 and IPO-4) were used in
an attempt to induce caspase activation in sperm fractions through Fas
mediated pathways. Neither antibody was able to induce increases in
caspase activity in sperm, though both were able to induce a dramatic
caspase activation in human blood neutrophils. Both Neutrophils and sperm
were treated identical regimens. At the end of incubation, neutrophils had
high levels of caspase activity, but sperm caspase activity remained at levels
comparable to control fractions.
The presence of Fas on the sperm plasma membrane has been
conclusively demonstrated using flow cytometry (Sakkas e ta i, 1999). The
Sakkas study demonstrated a distinct and significant difference between
fertile donors and oligozoospermic men in Fas expression on ejaculated
human sperm. Therefore, if an intact Fas mediated apoptotic system is
present in human sperm, treatment with an activating anti-Fas antibody could
be expected to induce apoptotic events in at least a significant subpopulation
of sperm. Sakkas postulated that ejaculated sperm lacked the full
complement of apoptotic machinery present in somatic cells and that, such
machinery, so much as present, were simply disconnected remnants of
incomplete apoptosis. The failure of either of the two anti-Fas antibody clones
used in the present study to induce caspase activation in sperm would tend to

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

75

support Sakkas incomplete apoptosis theory, at least so far as Fas induced
apoptotic caspase dependent pathways are concerned.
Flow cytometry results supported the theory that PS translocation is not
directly caspase dependent. Sperm has been shown to have Fas receptors
on the plasma membrane (Sakkas etaL, 1999). Treatment with an apoptosis
stimulating anti-Fas antibody resulted in no significant increase in PS
translocation and therefore would seem to rule out the type I apoptotic
pathways. Likewise, STS treatment also failed to stimulate PS translocation,
leaving Annexin-V binding levels equivalent to both control and Fas antibody
levels. The lack of stimulation of PS translocation in STS treated samples
suggests that if, mitochondria dependent or type II pathways are present, they
are not linked to PS translocation. The significant increase in Annexin-V
binding in fractions treated with cytotoxic (200 pM) levels of H2O2 may merely
be a secondary due to oxidative stress. Direct action of H2O2 on PS and/or
APT may cause the appearance of PS on the outer membrane leaflet. While
it was possible to stimulate Annexin-V binding in sperm, the stimulus for PS
translocation was different from that necessary in caspase assays. In flow
cytometry experiments, STS treatment, the only effective treatment for
stimulating caspase activity, resulted in no measurable increase in Annexin-VFITC binding.
Low motility fractions, representing (theoretically) lower quality live sperm
and sperm already dead, did not have any significant differences in Annexin-V
binding between any of the treatment fractions. As with caspase activity
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assays, sperm in low motility fractions appeared impervious to any of the
treatments. Annexin-V binding in the 200 pM fractions was somewhat higher,
but not significantly so, compared with other fractions.
The extremely low number of sperm in a semen sample exhibiting active
caspase-3 via immunofluorescent microscopy explains the difficulty in
detecting this enzyme in sperm fractions. Further, active caspase-3 was
always localized to the mid-piece region and, in some cases, a cytoplasmic
droplet. In somatic cells, procaspase-3 has been shown to have a
mitochondrial distribution as well as cytoplasmic (Mancini e ta i, 1998). In
Mancini’s research, procaspase-3 was activated and released from
mitochondria during induction of apoptosis. This same process may very well
be occurring in sperm, however, diffusion out of the immediate vicinity of the
mitochondria may be limited by compartmentalization characteristic of sperm
structure.
Sperm have been shown to have, at least, procaspases -3, -7, and -9, as
well as the mitochondria dependent, caspase independent factor AIF. In
some cases, active caspases -3 and -9 were detected. Bid, an important
protein in the induction of mitochondrial apoptotic pathways, was not detected
in any sperm fraction.
PARP-1, another marker of apoptosis was detected in neither of its
common forms. This feature makes sperm only the second, after
polymorphonuclear leukocytes, cell type that lacks this important protein.
Given the role o f PARP-1 in somatic cell DNA repair, the fact that PARP-1 is
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absent in sperm is not surprising. Mature spermatozoa, with their highly
compacted and virtually inaccessible DNA, would not have the need for
PARP-1. Even if PARP-1 proteins were present in sperm, it would be
necessary to unwind the sperm DNA in order to repair damaged sequences.
Do sperm undergo apoptosis? Sperm certainly do have some of the major
components necessary to undergo the process as it is understood today,
however, it is unclear how these components work together, if at all. It was
not possible to induce apoptosis using known stimuli of caspase dependent
pathways (anti-Fas antibodies), even though sperm have been shown to
express Fas receptors (Sakkas e ta i, 1999; Sakkas e ta i, 2002). Additional
evidence of the lack of involvement of caspases in sperm lies in flow
cytometry data. PS translocation during apoptosis has been viewed as a
caspase dependent phenomenon, yet, as with the caspase activity assays,
anti-Fas antibody treatment failed to promote this event. A possibility is that
some critical link in the caspase dependent pathway is absent, effectively
short-circuiting a cascade of apoptotic events.
The increase in caspase activity with STS treatment may indicate
mitochondrial pathways are active in sperm. However, BID was not detected
in protein immunoblots of sperm fractions. It is possible that BID is present in
sperm, except that the protein level in these experiments falls below the
threshold for immunoblots. AIF is present in sperm, however, it is not clear
whether any communication exists between the mid-piece and the nucleus.
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AIF exerts all of its influence in the nucleus where it causes DNA
fragmentation.
Sperm have many of the essential components for apoptosis, however,
what seems to be lacking fs a pathway for bringing together the components
for induction of apoptosis. It is clear that some apoptosis inducers used for
somatic cells fail to have the comparable effects on sperm. Perhaps other
inducers of apoptosis will be successfully in stimulating these events in sperm.
Or, as Sakkas suggests, maybe these proteins are merely leftovers from
defective or incomplete apoptosis during spermatogenesis.
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CHAPTER V
CONCLUSIONS
Specific aim one was to identify changes in ejaculated sperm normally
associated with apoptosis in somatic cells. It was expected that ejaculated
human sperm would have changes similar to those in somatic cells
undergoing apoptosis. Many of the hallmarks of apoptosis are
indemonstrable in ejaculated sperm. A common early apoptosis marker in
somatic ceils is loss of membrane asymmetry due PS translocation to the
outer membrane leaflet. This marker was identified to investigate specific aim
1. While sperm do exhibit PS translocation, pro-apoptotic stimuli involving a
Fas antibody and staurosporine, two potent inducers of apoptosis, failed to
elicit a detectable increase in PS translocation. Oxidative damage from H2O2
also induces apoptosis in somatic cells, however, a selected low concentration
(25 pM) of H2O2 was unsuccessful for inducing PS translocation. At 200 pM
H2O2 , a significant increase in PS translocation was observed. This significant
translocation may have been due to either simple oxidative damage to PS and
associated monitoring systems or may have been due to an induced
apoptosis-iike event in sperm.
Specific aim two was to determine the presence of caspases in ejaculated
sperm and whether they can be initiated by known pro-apoptotic agents. If
sperm were capable of apoptosis, the expected outcome of these studies
would have been that pro-apoptotic treatments would result in an increase in
caspase activity in sperm. With approximately 1000x less caspase activity per
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cell than stimulated PMN positive controls, the extremely low caspase activity
present in human sperm necessitated a t least 20 x 106 sperm be used for
each treatment. Fas antibody and H2O2 treatments resulted in no significant
induction of caspase activity. However, STS dfd result in significant induction
of caspase activity in both patient and donor high motility samples. The STS
induction is indicative of a mitochondrial dependent, type IMike, pathway in
sperm.
Specific aim three was to identify key apoptotic proteins in ejaculated
sperm, with the expectation that sperm would express similar apoptotic
proteins compared with somatic cells. Sperm were found to have
procaspases-3, -7, and -9 by protein immunoblot. Active caspase-3 was
present in sperm. Procaspase-7 and an intermediate form procaspase-7 were
also detected in sperm fractions, however, no active caspase-7 (neither 20
kDa subunit nor 11 kDa subunit) was observed. Procaspase-9 was found in
high and low motility fractions from both patients and donors. However, active
caspase-9 was only detected in a single patient low motility fraction. PARP-1,
a caspase-3 target, was not found in any sperm fraction, making sperm and
PMNs the only two cell types in which PARP-1 has not been detected
(Sanghavi, etal.t 1998). AIF, an important protein in caspase independent
DNA fragmentation, was found in all sperm fractions. Since mitochondrial are
present in sperm, the presence of AIF was expected. Bid, a cytoplasmic proapoptotic protein, was not detected in any sperm fraction. Bid may be totally
absent in sperm of simply below the threshold of detection for protein
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immunoblotting. Active-caspase-3 immunofluorescent microscopy with severe
oligoasthenoteratozoospermic patients was found to be comparable to
Weng’s (2002) observations for normozoospermic patients. Less than 1% of
the sperm evaluated exhibited positive immunofluorescence for active
caspase-3.
Specific aim four was to define differences between fertile donors and
infertility patients with regard to apoptotic markers. This specific aim was
accomplished by comparing caspase activity assays between donors and
patients. Patients had significantly higher basal levels of caspase activity
compared with fertile donors. STS treated patient high motility fractions also
were approximately twice the donor values.
Further studies will involve immunoblots of stimulated patient and donor
sperm fractions for caspases-7, -9, and -6. Caspase-8 has yet to be
evaluated using immunoblots in sperm fractions. PARP activity is present in
other cells in up to three other related proteins. Additional immunoblots are
necessary to evaluate whether these proteins are present in human sperm.
Additionally, it will be necessary to localize AIF in STS stimulated sperm to
determine whether this protein is released from sperm mitochondria and
whether it is capable of migration to the nucleus.
In summary, the following has been demonstrated in ejaculated
spermatozoa:
1. That an apoptotic membrane bio-marker PS is present in sperm and is
inducible through H2O2 treatment.
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2. Caspase activity in ejaculated sperm and that this activity is inducible.
3. The presence of procaspases-3, -7, and -9, as well as active caspases-3
and -9.
4. That PARP-1 is absent from human ejaculated spermatozoa.
5. That Bid, a pro-apoptotic protein when processed by caspase-8, is absent
in human spermatozoa.
The potential significance of these studies lies in the benefits towards
treating infertility patients. Identification of apoptosis bio-markers in otherwise
normal semen samples from infertility patients may serve to identify a
subpopulation of male factor infertility patients. The possibility exists that
inappropriate apoptosis in sperm may be prevented or arrested through
inhibiting these process.
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